CLRD — Clearday Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $1.35m
- -$42.23m
- $12.49m
Annual cashflow statement for Clearday, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.13 | -9.23 | -2.96 | -19.5 | -14.5 |
| Depreciation | |||||
| Non-Cash Items | 0.056 | 0.087 | -0.106 | 16.9 | 1.78 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.129 | -0.481 | -0.113 | -0.546 | 8.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -6.93 | -8.8 | -3.14 | -2.61 | -3.98 |
| Capital Expenditures | -0.189 | 0 | — | -1.61 | -0.029 |
| Purchase of Fixed Assets | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | — | — | 1.22 | 1.12 | 1.08 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.189 | 0 | 1.22 | -0.493 | 1.05 |
| Financing Cash Flow Items | — | — | — | 0.259 | -0.623 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.68 | 3.9 | 2.48 | 3.21 | 2.16 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.56 | -4.9 | 0.563 | 0.105 | -0.769 |